Negma Group

Bloom is a financial technology company that operates a digital banking platform aimed at providing regulated banking services to consumers. Its application allows users to open bank accounts online, access fee-free bank accounts in both Sudanese and US dollars, and obtain free USD Mastercards. The platform facilitates free transfers within Sudan and offers complimentary international remittance services from various countries. By focusing on innovative and inclusive financial products, Bloom seeks to enhance the financial well-being of its customers.

Theneo is a developer of AI-driven software that focuses on creating high-quality and interactive API documentation. The company's innovative tool automates the content writing process for application programming interfaces, significantly reducing the workload of development teams. This automation allows both developers and non-technical team members to enhance productivity and standardize documentation efficiently. By streamlining the documentation process, Theneo provides a cost-effective solution that meets the needs of modern software development.

Evaxion Biotech A/S is a clinical-stage biotechnology company focused on utilizing artificial intelligence to decode the human immune system and develop innovative immunotherapies for cancer and infectious diseases. The company leverages its proprietary AI-immunology technology to create a diverse pipeline of product candidates, which includes three patient-specific cancer immunotherapies—two of which are in Phase I/IIa clinical trials. In addition to its cancer treatments, Evaxion is also advancing a portfolio of vaccines aimed at preventing bacterial and viral infections, with one program targeting Methicillin-resistant Staphylococcus aureus currently in preclinical development. By combining AI with immunology, Evaxion seeks to improve therapeutic efficacy for patients with unmet medical needs.

Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Supply@ME is an independent fintech company based in London, United Kingdom, specializing in inventory monetization services for manufacturing and trading companies across Europe. The company offers a proprietary platform that allows businesses to convert their inventory into liquid assets, enhancing their financial flexibility. By providing innovative solutions, Supply@ME aims to support companies in optimizing their supply chains and improving cash flow management. Formerly a subsidiary of The AvantGarde Group, Supply@ME has established itself as a key player in the fintech sector, focusing on the unique needs of its clients in the manufacturing and trading industries.

IGEA Pharma N.V. is a health-tech and med-tech company based in Hoofddorp, the Netherlands, that focuses on developing and commercializing innovative products in the United States. The company offers Alz1, an at-home lab test kit designed to measure non-bound copper levels in the blood, alongside dietary supplements aimed at reducing heavy metal content in the body. Igea Pharma also manufactures dry aerosol generators for sanitizing air and surfaces, as well as devices for air sterilization and purification. With over 20 years of research dedicated to combating Alzheimer’s Disease and diabetes prevention, IGEA Pharma leverages its expertise to provide effective biomedical solutions and laboratory analysis services.